Orthokeratology Market to exceed US$ 37.6 million by 2027

Overview

Orthokeratology (Ortho-k) is a procedure that involves gradually reshaping the contour of the cornea using specially constructed contact lenses in order to decrease myopia (nearsightedness). It is a non-surgical treatment that, when compared to refractive surgery, has a lower risk. To repair or manage myopia, ortho-k lenses are also known as corneal contouring contact lenses or nighttime contact lenses.

Myopia, astigmatism, and presbyopia are the most common refractive defects treated with these lenses. Ortho-k is also used to correct presbyopia and delay the growth of juvenile myopia in some circumstances. As per a research published in 2015 by the American Academy of Optometry, using orthokeratology lenses resulted in a continuous drop in myopia progression of 45 percent over two years and 30 percent over five years in terms of axial length.

The global orthokeratology market was worth US$ 37.6 million in 2017, and it is anticipated to grow at a CAGR of 7.0 percent between 2018 and 2026.

Request for a Sample Report at – https://www.coherentmarketinsights.com/insight/request-sample/2193 

Drivers

Myopia and severe myopia are becoming more common across the world at an alarming rate. Myopia is a serious public health problem, with high myopia ranking second in the world as the primary cause of visual impairment. According to a 2016 research by the National Center for Biotechnology Information (NCBI), over half of the urban population in East Asia suffers from myopia, with the incidence among graduates was about 90 percent.

Furthermore, the beginning of myopia-related visual problems occurs earlier than other causes of visual impairment, such as glaucoma, and hence its influence on quality of life is seen earlier. According to a 2018 research published in the Eye Contact Lens magazine, the cost of eye disorders in the U.S. is about US$ 139 billion, with around US$ 16 billion spent on myopia treatment alone. As a result, approaches for preventing and managing myopia are in great demand all around the world.

Furthermore, prolonged use of computers, cellphones, and tablets causes digital eye strain, which can result in irreversible eye damage in children and the younger population. Orthokeratology is particularly appropriate for young individuals whose nearsightedness is gradually growing. All of these reasons are propelling the expansion of the global orthokeratology market by boosting the need for ortho-K.

Restraints

Complications such as the development of microbial keratitis, an inadequate training for clinicians and users, poor response with lens care regimens, incorrect fitting procedures, and missed routine follow-ups, according to the NCBI 2016 study, are expected to hamper growth of the global orthokeratology market.

Fitting orthokeratology lenses takes longer and needs more experience than fitting normal contact lenses. Ortho-K lenses need numerous doctor visits and perhaps multiple sets of lenses. As a result, total treatment costs rise, which could be a major issue restricting the global orthokeratology market’s growth.

Furthermore, the cost of ortho-k, including follow-up treatment, varies greatly according to the kind and degree of refractive defect, as well as the length of time it takes to cure myopia. Ortho-k costs in the U.S. varied from $1,000 to 2,000 dollars in 2016. Depending on the severity of the case, this fee might reach US$ 4,000. Vision insurance companies do not cover orthokeratology entirely.

Regional Analysis

Owing to the rising prevalence of short-sightedness among the European population, Europe is anticipated to produce a large revenue share in the global orthokeratology market by 2026. According to a research released in 2015 by Ulster University, the rate of short-sightedness in the United Kingdom has risen in the last 50 years, owing to children not spending enough time outside. Myopia affects about 23% of teenagers of the country.

The steep growth in pediatric myopia in Asia’s population is the primary driver of the global orthokeratology market in the area. According to research published in the Lancet Journal in 2012, excessive myopia affects approximately 20% of East Asian secondary school students and is linked to sight-threatening permanent diseases. Myopia is most common in East Asia, as per a 2016 research released by the National Center for Biotechnology Information (NCBI), with 50 percent of myopic individuals living in Japan, China, Singapore, and the Republic of Korea.

Major Players Are: Autek China, Alpha Corporation, Bausch and Lomb Inc., Euclid Systems, E & E Optics, Essilor International S.A., GP Specialists, Paragon Vision Sciences, Procornea, and Taiwan Macro Vision Corporation.

Purchase This Premium Report Here With Discounted Price (Flat US $2000 Off) – https://www.coherentmarketinsights.com/promo/buynow/2193

Contact Us:

Name: Mr. Shah
Phone: US +12067016702 / UK +4402081334027
Email: sales@coherentmarketinsights.com

Overview

Orthokeratology (Ortho-k) is a procedure that involves gradually reshaping the contour of the cornea using specially constructed contact lenses in order to decrease myopia (nearsightedness). It is a non-surgical treatment that, when compared to refractive surgery, has a lower risk. To repair or manage myopia, ortho-k lenses are also known as corneal contouring contact lenses or nighttime contact lenses.

Myopia, astigmatism, and presbyopia are the most common refractive defects treated with these lenses. Ortho-k is also used to correct presbyopia and delay the growth of juvenile myopia in some circumstances. As per a research published in 2015 by the American Academy of Optometry, using orthokeratology lenses resulted in a continuous drop in myopia progression of 45 percent over two years and 30 percent over five years in terms of axial length.

The global orthokeratology market was worth US$ 37.6 million in 2017, and it is anticipated to grow at a CAGR of 7.0 percent between 2018 and 2026.

Request for a Sample Report at – https://www.coherentmarketinsights.com/insight/request-sample/2193 

Drivers

Myopia and severe myopia are becoming more common across the world at an alarming rate. Myopia is a serious public health problem, with high myopia ranking second in the world as the primary cause of visual impairment. According to a 2016 research by the National Center for Biotechnology Information (NCBI), over half of the urban population in East Asia suffers from myopia, with the incidence among graduates was about 90 percent.

Furthermore, the beginning of myopia-related visual problems occurs earlier than other causes of visual impairment, such as glaucoma, and hence its influence on quality of life is seen earlier. According to a 2018 research published in the Eye Contact Lens magazine, the cost of eye disorders in the U.S. is about US$ 139 billion, with around US$ 16 billion spent on myopia treatment alone. As a result, approaches for preventing and managing myopia are in great demand all around the world.

Furthermore, prolonged use of computers, cellphones, and tablets causes digital eye strain, which can result in irreversible eye damage in children and the younger population. Orthokeratology is particularly appropriate for young individuals whose nearsightedness is gradually growing. All of these reasons are propelling the expansion of the global orthokeratology market by boosting the need for ortho-K.

Restraints

Complications such as the development of microbial keratitis, an inadequate training for clinicians and users, poor response with lens care regimens, incorrect fitting procedures, and missed routine follow-ups, according to the NCBI 2016 study, are expected to hamper growth of the global orthokeratology market.

Fitting orthokeratology lenses takes longer and needs more experience than fitting normal contact lenses. Ortho-K lenses need numerous doctor visits and perhaps multiple sets of lenses. As a result, total treatment costs rise, which could be a major issue restricting the global orthokeratology market’s growth.

Furthermore, the cost of ortho-k, including follow-up treatment, varies greatly according to the kind and degree of refractive defect, as well as the length of time it takes to cure myopia. Ortho-k costs in the U.S. varied from $1,000 to 2,000 dollars in 2016. Depending on the severity of the case, this fee might reach US$ 4,000. Vision insurance companies do not cover orthokeratology entirely.

Regional Analysis

Owing to the rising prevalence of short-sightedness among the European population, Europe is anticipated to produce a large revenue share in the global orthokeratology market by 2026. According to a research released in 2015 by Ulster University, the rate of short-sightedness in the United Kingdom has risen in the last 50 years, owing to children not spending enough time outside. Myopia affects about 23% of teenagers of the country.

The steep growth in pediatric myopia in Asia’s population is the primary driver of the global orthokeratology market in the area. According to research published in the Lancet Journal in 2012, excessive myopia affects approximately 20% of East Asian secondary school students and is linked to sight-threatening permanent diseases. Myopia is most common in East Asia, as per a 2016 research released by the National Center for Biotechnology Information (NCBI), with 50 percent of myopic individuals living in Japan, China, Singapore, and the Republic of Korea.

Major Players Are: Autek China, Alpha Corporation, Bausch and Lomb Inc., Euclid Systems, E & E Optics, Essilor International S.A., GP Specialists, Paragon Vision Sciences, Procornea, and Taiwan Macro Vision Corporation.

Purchase This Premium Report Here With Discounted Price (Flat US $2000 Off) – https://www.coherentmarketinsights.com/promo/buynow/2193

Contact Us:

Name: Mr. Shah
Phone: US +12067016702 / UK +4402081334027
Email: sales@coherentmarketinsights.com